JAC Advance Access published online on January 23, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Microbiology, Medical School, University of Thessaly, Mezourlo, Larissa, Greece
* To whom correspondence should be addressed. Objectives: To investigate the resistance mechanisms and the genetic relationship of imipenem-resistant Acinetobacter baumannii isolates recovered in the intensive care unit (ICU) of a tertiary care hospital. Methods: Imipenem-resistant A. baumannii clinical and environmental isolates were collected in the ICU of the Red Cross General Hospital, Athens, Greece between March and October 2002. The isolates were tested by Etest MBL, PCR, RT-PCR and sequencing for carbapenemase-encoding genes, PFGE and synergy experiments using meropenem and the efflux pump inhibitor carbonyl cyanide chlorophenylhydrazone. Results: During the study period, 15 clinical and two environmental imipenem-resistant (MIC 8 to >128 mg/L) A. baumannii isolates were recovered. PFGE showed six different clones that included both clinical and environmental isolates. All 17 isolates were negative by Etest MBL and PCR for genes blaIMP, blaVIM, blaSPM, blaOXA-23-like and blaOXA-24-like. Genes blaOXA-51-like and blaOXA-58-like were amplified from 15 and 14 isolates, respectively. Sequencing of blaOXA-51-like amplicons identified blaOXA-66 (nine cases) and blaOXA-69 (six cases), whereas blaOXA-58-like sequences were classical blaOXA-58. Reverse transcriptase-PCR showed that blaOXA-51-like genes were expressed in 12 and blaOXA-58 in 10 isolates; in these isolates, inhibition of OXA enzymes by 200 mM of NaCl reduced carbapenem MICs by up to 4-fold. Overexpression of proton-gradient dependent efflux pumps did not contribute to carbapenem resistance in any isolate. Similarly, although AmpC expression was demonstrated in eight isolates, inhibition of AmpC with cloxacillin did not reduce the MICs of carbapenems significantly. Conclusions: These findings indicate wide dissemination of OXA-58 carbapenemase, which contributes, at least partially, to the imipenem resistance of unrelated A. baumannii isolates in our ICU.
Received November 17, 2005
Revised December 16, 2005
Accepted December 23, 2005
Brief report
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
S. Pournaras 1,
A. Markogiannakis 2,
A. Ikonomidis 1,
L. Kondyli 3,
K. Bethimouti 3,
A. N. Maniatis 1,
N. J. Legakis 2,
and
A. Tsakris 2 *
2 Department of Microbiology, Medical School, University of Athens, 11527 Athens, Greece
3 Department of Clinical Microbiology, Red Cross Hospital, Athens, Greece
A. Tsakris, E-mail: atsakris{at}med.uoa.gr
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. McCracken, M. DeCorby, J. Fuller, V. Loo, D. J. Hoban, G. G. Zhanel, and M. R. Mulvey Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007 J. Antimicrob. Chemother., September 1, 2009; 64(3): 552 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Giannouli, F. Tomasone, A. Agodi, H. Vahaboglu, Z. Daoud, M. Triassi, A. Tsakris, and R. Zarrilli Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals J. Antimicrob. Chemother., April 1, 2009; 63(4): 828 - 830. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tsakris, I. Kristo, A. Poulou, K. Themeli-Digalaki, A. Ikonomidis, D. Petropoulou, S. Pournaras, and D. Sofianou Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory J. Clin. Microbiol., February 1, 2009; 47(2): 362 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tsakris, I. Kristo, A. Poulou, F. Markou, A. Ikonomidis, and S. Pournaras First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests J. Antimicrob. Chemother., December 1, 2008; 62(6): 1257 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zarrilli, D. Vitale, A. Di Popolo, M. Bagattini, Z. Daoud, A. U. Khan, C. Afif, and M. Triassi A Plasmid-Borne blaOXA-58 Gene Confers Imipenem Resistance to Acinetobacter baumannii Isolates from a Lebanese Hospital Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4115 - 4120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vasilev, G. Reshedko, R. Orasan, M. Sanchez, J. Teras, T. Babinchak, G. Dukart, A. Cooper, N. Dartois, H. Gandjini, et al. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae J. Antimicrob. Chemother., September 1, 2008; 62(suppl_1): i29 - i40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Poirel, W. Mansour, O. Bouallegue, and P. Nordmann Carbapenem-Resistant Acinetobacter baumannii Isolates from Tunisia Producing the OXA-58-Like Carbapenem-Hydrolyzing Oxacillinase OXA-97 Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1613 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawamura-Sato, J.-i. Wachino, T. Kondo, H. Ito, and Y. Arakawa Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material J. Antimicrob. Chemother., March 1, 2008; 61(3): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ikonomidis, E. Ntokou, A. N. Maniatis, A. Tsakris, and S. Pournaras Hidden VIM-1 Metallo- -Lactamase Phenotypes among Acinetobacter baumannii Clinical Isolates J. Clin. Microbiol., January 1, 2008; 46(1): 346 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo Global Challenge of Multidrug-Resistant Acinetobacter baumannii Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3471 - 3484. [Full Text] [PDF]
|
|
|
|
|
|
A. Bertini, L. Poirel, S. Bernabeu, D. Fortini, L. Villa, P. Nordmann, and A. Carattoli Multicopy blaOXA-58 Gene as a Source of High-Level Resistance to Carbapenems in Acinetobacter baumannii Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2324 - 2328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Koh, L.-H. Sng, G. C. Y. Wang, L.-Y. Hsu, and Y. Zhao IMP-4 and OXA {beta}-lactamases in Acinetobacter baumannii from Singapore J. Antimicrob. Chemother., April 1, 2007; 59(4): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hujer, A. M. Hujer, E. A. Hulten, S. Bajaksouzian, J. M. Adams, C. J. Donskey, D. J. Ecker, C. Massire, M. W. Eshoo, R. Sampath, et al. Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4114 - 4123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tsakris, A. Ikonomidis, S. Pournaras, N. Spanakis, and A. Markogiannakis Carriage of OXA-58 but not of OXA-51 {beta}-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii J. Antimicrob. Chemother., November 1, 2006; 58(5): 1097 - 1099. [Full Text] [PDF]
|
|
|
|
|
|
P. Bogaerts, T. Naas, I. Wybo, C. Bauraing, O. Soetens, D. Pierard, P. Nordmann, and Y. Glupczynski Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium J. Clin. Microbiol., November 1, 2006; 44(11): 4189 - 4192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Peleg, J. M. Bell, A. Hofmeyr, and P. Wiese Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes J. Antimicrob. Chemother., April 1, 2006; 57(4): 794 - 795. [Full Text] [PDF]
|
|